⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 21, 2024EBioMedicineOpen Access

Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform

Azadeh Feizpour James D. Doecke Vincent Doré Natasha Krishnadas Kun Lun Huang Pierrick Bourgeat Simon M. Laws Christopher Fowler Joanne Robertson Lucy Mackintosh Scott Ayton Ralph N. Martins Stephanie Rainey-Smith Kevin Taddei Larry D. Ward Eddie Stage Anthony W. Bannon Colin L. Masters Jürgen Fripp VL Villemagne Christopher Cleon Rowe

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

NHMRC grants 1132604, 1140853, 1152623 and AbbVie.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Feizpour et al. (2024) studied this question.

synapsesocial.com/papers/69d99d5c2a25b240b7a3d1af https://doi.org/10.1016/j.ebiom.2024.105405

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Donanemab in Early Symptomatic Alzheimer DiseaseRCT · 2023 · 2,878 citations
2Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s diseaseOriginal Research · 2022 · 519 citations
3Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer DiseaseCohort Study · 2020 · 384 citations
4Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s diseaseCohort Study · 2020 · 368 citations
5Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyCross-Sectional Study · 2022 · 286 citations

Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology2024
Preliminary performance of the Lumipulse G pTau 217 Plasma prototype assay on plasma samples2023
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup2024
Serum neurofilament light chain and the 2024 McDonald criteria for multiple sclerosis: a retrospective cohort studyEBioMedicine · 2026
Advances in the management of pneumonia caused by drug-resistant bacteria: from antimicrobial optimisation to integrated treatment adaptationEBioMedicine · 2026

More from EBioMedicine

More from University of Pittsburgh

More from The University of Melbourne

More from Commonwealth Scientific and Industrial Research Organisation

More from Murdoch University

More from Edith Cowan University

More from Florey Institute of Neuroscience and Mental Health

More from Austin Health

More from AbbVie (United States)

More from Australian e-Health Research Centre

More from Australian Alzheimer’s Research Foundation